Browsing: highlights

BioNTech reported Q3 revenue of €1.3 billion, down from €1.5 billion a year earlier due to weaker COVID-19 vaccine demand, but raised its 2026 revenue outlook to €1.7 billion–€1.9 billion. The company ended the quarter with €16.2 billion in cash and investments.

Third-quarter results improved: Adjusted EBITDA rose to CAD 5 million from CAD 3.5 million, while net income increased to CAD 4.4 million, or CAD 0.23 per share. A 17% increase in average selling prices and stronger Maine operations offset a 14% decline in sales volumes.

Weyerhaeuser reported mixed third-quarter results: net earnings were $61 million on $1.9 billion in sales, while adjusted EBITDA rose 14% year over year to $248 million. Stronger Timberlands performance partly offset weakness in Wood Products amid high interest rates, softer housing demand and rising costs.